Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other financing activities (2020 - 2021)

Arcutis Biotherapeutics (ARQT) has 2 years of Other financing activities data on record, last reported at $1.6 million in Q4 2021.

  • For Q4 2021, Other financing activities rose 447.56% year-over-year to $1.6 million; the TTM value through Dec 2023 reached $1.2 million, changed N/A, while the annual FY2022 figure was $2.2 million, 33.6% up from the prior year.
  • Other financing activities reached $1.6 million in Q4 2021 per ARQT's latest filing, up from -$471000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.6 million in Q4 2021 and bottomed at -$471000.0 in Q4 2020.